COMPANY

Veriskin, Inc.

HQ: San Diego, CA source · veriskin.com ↗ · West Coast

Keywords: oncology

Location: San Diego, CA · source · Oct 13, 2026

Profile checked Oct 10, 2026

9NIH grants

NIH awards 9

Annual award amounts. Total $6.9M.

Jul 16, 2024 NIH award 5R44CA203038-06 FY2024: $742,845 awarded for that fiscal year; activity R44 (SBIR); PI CHACHISVILIS, MIRIANAS; recipient as written: VERISKIN, INC., SAN DIEGO, CA. Pivotal Clinical Study of the TruScore Dev source ↗
Jun 21, 2023 NIH award 5R44CA203038-05 FY2023: $757,314 awarded for that fiscal year; activity R44 (SBIR); PI CHACHISVILIS, MIRIANAS; recipient as written: VERISKIN, INC., SAN DIEGO, CA. Pivotal Clinical Study of the TruScore Dev source ↗
Jul 14, 2022 NIH award 2R44CA203038-04 FY2022: $1,499,425 awarded for that fiscal year; activity R44 (SBIR); PI CHACHISVILIS, MIRIANAS; recipient as written: VERISKIN, INC., SAN DIEGO, CA. Pivotal Clinical Study of the TruScore D source ↗
Feb 26, 2021 NIH award 5R44CA250768-02 FY2021: $833,460 awarded for that fiscal year; activity R44 (SBIR); PI CHACHISVILIS, MIRIANAS; recipient as written: VERISKIN, INC., SAN DIEGO, CA. Clinical performance of hemodynamics-based source ↗
Mar 13, 2020 NIH award 1R44CA250768-01 FY2020: $1,164,975 awarded for that fiscal year; activity R44 (SBIR); PI CHACHISVILIS, MIRIANAS; recipient as written: VERISKIN, INC., SAN DIEGO, CA. Clinical performance of hemodynamics-bas source ↗
Aug 8, 2018 NIH award 3R44CA203038-03S1 FY2018: $2,000 awarded for that fiscal year; activity R44 (SBIR); PI CHACHISVILIS, MIRIANAS; recipient as written: VERISKIN, INC., SAN DIEGO, CA. Hemodynamic Noninvasive Skin Cancer Diagno source ↗
May 1, 2017 NIH award 5R44CA203038-03 FY2017: $896,930 awarded for that fiscal year; activity R44 (SBIR); PI CHACHISVILIS, MIRIANAS; recipient as written: VERISKIN, INC., SAN DIEGO, CA. Hemodynamic Noninvasive Skin Cancer Diagno source ↗
Jan 18, 2017 NIH award 6R44CA203038-02 FY2016: $521,409 awarded for that fiscal year; activity R44 (SBIR); PI CHACHISVILIS, MIRIANAS; recipient as written: VERISKIN, INC., SAN DIEGO, CA. Hemodynamic Noninvasive Skin Cancer Diagno source ↗
Apr 27, 2016 NIH award 1R44CA203038-01A1 FY2016: $455,835 awarded for that fiscal year; activity R44 (SBIR); PI CHACHISVILIS, MIRIANAS; recipient as written: VERISKIN, INC., SAN DIEGO, CA. Hemodynamic Noninvasive Skin Cancer Diag source ↗